Jonathan Pearce, who has more than 20 years’ experience leading UK charities including Lymphoma Action, has been appointed chief executive officer at Antibiotic Research UK.
He has also previously led blood cancer charity DKMS and chaired Cancer52, the membership organisation for rare and less common cancer charities.
Pearce has joined this month taking over from the charity’s founder Colin Garner, who retired in July.
“I was immediately drawn to the cause of Antibiotic Research UK with its focus on bringing about fundamental change while also delivering essential support services,” said Pearce.
“Increasingly, I have seen how cancer patients are left vulnerable as infections become resistant to existing antibiotics. And cancer is just one of many medical conditions that rely on antibiotics for treatments to be safe and effective. I have come to appreciate that tackling antibiotic resistance is one of the most urgent global health challenges of our time.
“I look forward to meeting all the incredible partners, volunteers, fundraisers, advocates and patients and their families involved in the work of this amazing charity. I am excited to bring my experience to bear on growing on the strong foundations already in place at Antibiotic Research UK.”
The charity’s chair Simon Dukes added “The entire Trustee Board recognised Jonathan as an exceptional candidate and voted unanimously to appoint him.
“During the selection process, Jonathan outlined a clear vision on how to build on the successes of Antibiotic Research UK thus far, and he demonstrated the skills to influence and lead the charity effectively in the future. We look forward to working with him.”
Latest News
-
Former Salvation Army worker struck off after alleged sex with ‘vulnerable’ ex-resident
-
British Heart Foundation reveals extent of retail losses as it starts closing 150 shops
-
Dan Francis: Thinking differently about charity leadership
-
Friday funding round up – 25 September
-
Lifeboat charity crew tracked then subjected to ‘inflammatory’ social media attack
-
Arts Council England pledges to boost ‘local expertise’ in funding decisions
Beyond the funding squeeze: Using equities to secure your charity’s future
With charities facing increasing financial pressure and traditional income streams under strain, making investments work harder has never been more important. M&G’s Richard Macey and Michael Stiasny join Charity Times to discuss why equities remain a vital long-term asset class for charities, how organisations can balance income generation and growth, and the opportunities the current market environment may offer to help strengthen financial resilience.
Charity Times Awards 2023
Charity Times video Q&A: In conversation with Hilda Hayo, CEO of Dementia UK
Charity Times editor, Lauren Weymouth, is joined by Dementia UK CEO, Hilda Hayo to discuss why the charity receives such high workplace satisfaction results, what a positive working culture looks like and the importance of lived experience among staff. The pair talk about challenges facing the charity, the impact felt by the pandemic and how it's striving to overcome obstacles and continue to be a highly impactful organisation for anybody affected by dementia.
© 2021 Perspective Publishing Privacy & Cookies
Recent Stories